A Partner for Your Research
Ensigna Biosystems is a contract research organization that provides cutting-edge molecular pathology and genomic services to the biopharmaceutical industry. By combining traditional pathology services with genomics, Ensigna Biosystems is able to characterize biological samples based on protein expression, mRNA levels and mutational status, thus enabling the development of targeted therapies and the implementation of personalized medicine.
In this era of targeted therapies, histological characterization of tumor samples is still an essential part of pathology, but it is no longer sufficient. Molecular characterization of tumor samples is becoming essential to the development and use of targeted therapies for cancer. Ensigna Biosystems offers a full range of molecular pathology services.
Understanding the genetic aberrations that drive tumor cells is the foundation of oncology drug discovery. Ensigna Biosystems offers genomic analysis to complement our pathology services. Using quantitative PCR, the NanoString® technology and targeted sequencing using NGS technology, we identify molecular subtypes, mutations and chromosomal translocations.
We apply our unique blend of expertise and state of the art technology to conduct complex research studies. Biomarker discovery, pharmacogenomics and toxicogenomics are an essential part of drug development and Ensigna Biosystems can be a research partner to advance your drug discovery projects.